• COMPANY
    • LEADERSHIP
    • CAREERS
    • NIH GRANT SUPPORT
    • CONTACT US
    • Non Gamstop Casinos
    • Casinos Not On Gamstop
  • TECHNOLOGY
  • APPLICATIONS
    • ALLOSTERIC TARGETS
    • SECONDARY SCREENING & MECHANISM OF ACTION
    • COMPLEX TARGETS
    • TRUBIND AT WORK
      • ION CHANNEL INHIBITORS
      • PPI INTERACTIONS
      • TARGETING GPCRs
      • KINASE INTERACTIONS
  • DRUG DISCOVERY SERVICES
    • Assay Development
    • Secondary Screening
    • Binding Characterization Process
    • PHARMACEUTICAL PROJECTS
  • PRODUCTS
  • LITERATURE
  • NEWS
  • EVENTS
    • On-Demand Webinars
    • Exhibitions
DRUG DISCOVERY SERVICES SECONDARY SCREENING

SECONDARY SCREENING SERVICE

MSI offers a full-service contract research option, through which a customer gains access to a dedicated, highly experienced MSI scientist and BSI instrumentation for an extended period, thereby offering an ‘integrated’ CRO model that delivers high-quality technical expertise to support multiple projects.

While maintaining the advantages of the Assay Development modular project construction and implementation, our Secondary Screening Service effectively gives you an additional FTE to apply to a range of projects.

With a highly experienced contract scientist fully supported with BSI instrumentation as part of your team, you can drive forward your drug discovery in a much reduced time period by:

•   Increasing the efficiency of your whole discovery process

•   Addressing multiple compounds & targets in parallel

•   Undertaking deeper MOA and target-compound characterization

•   Guide medicinal chemistry and pharmacology decision making

Contact us to discuss how adding a dedicated MSI scientist to your team could galvanize your membrane-based discovery programs.

 

DRUG DISCOVERY SERVICES

  • ASSAY DEVELOPMENT
  • SECONDARY SCREENING
  • BINDING CHARACTERIZATION PROCESS
  • PHARMACEUTICAL PROJECTS

ON-DEMAND WEBINARS

  • Interrogating Ligand: Target Interactions Using Back-Scattering Interferometry Yields Mechanistic Insight and Aids in Compound PrioritizationBy MSI on January 26, 2016
  • Review of Recent Publications Featuring Binding Data Produced by MSIBy MSI on January 26, 2016
  • Conformation-Sensitive Assay Detection for Accelerated Drug Discovery ResearchBy MSI on February 10, 2015
  • Evaluation of the MoA of Allosteric Modulators and Its Application to Drug Discovery using Back-Scattering InterferometryBy MSI on November 13, 2014
  • Using BSI to Investigate Positive Allosteric Modulators of the M4 ReceptorBy MSI on September 3, 2014

Read about our low-risk, high-value Target-Ligand Binding Characterization Process that a majority of the top ten pharmaceutical and biotechnology companies have used to solve drug binding characterization problems impacting early discovery through IND submission.

DOWNLOAD NOW>
© Copyright 2015 by Molecular Sensing, Inc.
  • /Terms of Use
  • /Privacy Policy